Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Paying user area

Try for free

Moderna Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get full access to the entire website from $10.42/mo, or
get 1-month access to Moderna Inc. for $22.49.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Moderna Inc., consolidated balance sheet: assets

US$ in millions

		Dec 31, 2023		Dec 31, 2022		Dec 31, 2021		Dec 31, 2020		Dec 31, 2019
	Cash and cash equivalents
	Investments
	Accounts receivable, net
	Inventory
	Prepaid services
	Down payments to manufacturing vendors
	Down payments for materials and supplies
	Collaboration receivable
	Interest receivable
	Value added tax receivable
	Income tax receivable
	Tenant improvement allowance receivable
	Prepaid income taxes
	Convertible note receivable
	Other current assets
	Prepaid expenses and other current assets
	Current assets
	Investments, non-current
	Property, plant and equipment, net
	Right-of-use assets, operating leases
	Deferred tax assets
	Down payments and prepayments, non-current
	Inventory, non-current
	Equity investments
	Goodwill
	Finite-lived intangible asset
	Restricted cash
	Other
	Other non-current assets
	Non-current assets
	Total assets

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Assets: Selected Items

Download chart

Balance sheet item	Description	The company
Current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Moderna Inc. current assets decreased from 2021 to 2022 and from 2022 to 2023.
Property, plant and equipment, net	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Moderna Inc. property, plant and equipment, net increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Non-current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.	Moderna Inc. non-current assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Total assets	Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Moderna Inc. total assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.

Current Assets: Selected Items